Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Landiolol vs digoxin in atrial fibrillation/flutter with low cardiac function
jRCT2080221409Phase 3
- Sponsor
- Ono Pharmaceutical
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of landiolol in Atrial fibrillation (AFib), atrial flutter (AFL) and heart failure (HF) (2 arms), sponsored by Ono Pharmaceutical.
02
Drugs
landiolol
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)heart failure (HF)
Beyond the preview
Go deeper on jRCT2080221409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221409.